Bill
Bill > S1614
NJ S1614
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
summary
Introduced
02/14/2022
02/14/2022
In Committee
06/27/2023
06/27/2023
Crossed Over
06/30/2023
06/30/2023
Passed
06/30/2023
06/30/2023
Dead
Signed/Enacted/Adopted
07/10/2023
07/10/2023
Introduced Session
2022-2023 Regular Session
Bill Summary
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
AI Summary
This bill requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers, and limits cost sharing for health insurance coverage of insulin. Specifically, it mandates that individual, group, and small employer health plans in New Jersey cover at least one epinephrine auto-injector device and a prescription asthma inhaler, with no deductible and limited copayments. It also caps copayments for insulin at $35 per 30-day supply, and applies these provisions to high-deductible health plans to the maximum extent permitted by federal law.
Committee Categories
Budget and Finance, Business and Industry
Sponsors (14)
Linda Greenstein (D)*,
John McKeon (D)*,
Paul Moriarty (D)*,
Nellie Pou (D)*,
Annette Quijano (D)*,
Troy Singleton (D)*,
Joe Vitale (D)*,
Daniel Benson (D),
Sandra Cunningham (D),
Patrick Diegnan (D),
Nia Gill (D),
Teresa Ruiz (D),
Gary Schaer (D),
Shirley Turner (D),
Last Action
Approved P.L.2023, c.105. (on 07/10/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...